LJ, M., L, S., AA, K., JL, R., EY, C., RC, Y., . . . FV, R. (2020). Pharmacologic induction of innate immune signaling directly drives homologous recombination deficiency. Proceedings of the National Academy of Sciences of the United States of America, 117(30), 17785. https://doi.org/10.1073/pnas.2003499117
Chicago Style (17th ed.) CitationLJ, McLaughlin, et al. "Pharmacologic Induction of Innate Immune Signaling Directly Drives Homologous Recombination Deficiency." Proceedings of the National Academy of Sciences of the United States of America 117, no. 30 (2020): 17785. https://doi.org/10.1073/pnas.2003499117.
MLA (9th ed.) CitationLJ, McLaughlin, et al. "Pharmacologic Induction of Innate Immune Signaling Directly Drives Homologous Recombination Deficiency." Proceedings of the National Academy of Sciences of the United States of America, vol. 117, no. 30, 2020, p. 17785, https://doi.org/10.1073/pnas.2003499117.